Kenneth Hugh Mayer

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study.

Amico KR, Mayer KH, Landovitz RJ, Marzinke M, Hendrix C, McCauley M, Wilkin T, Gulick R.

AIDS Behav. 2023 Nov 10. PMID: 37947968

Increasing Spiritual Beliefs are Associated With Lower HIV Incidence Among Black Men Who Have Sex With Men: Results From HPTN 061 Longitudinal Study.

Ransome Y, Taggart T, Huang AS, Vermund SH, Mayer KH, Nunn AS.

J Acquir Immune Defic Syndr. 2023 11 01. 94(3):196-202. PMID: 37850978

Age Differences in the Associations Between Incarceration and Subsequent Substance Use, Sexual Risk-Taking, and Incident STI Among Black Sexual Minority Men and Black Transgender Women in the HIV Prevention Trials 061 Cohort.

Feelemyer J, Abrams J, Mazumdar M, Irvine NM, Scheidell JD, Turpin RE, Dyer TV, Brewer RA, Hucks-Ortiz C, Caniglia EC, Remch M, Scanlon F, Gaydos CA, Sandh S, Cleland CM, Mayer KH, Khan MR.

Am J Mens Health. 2023 Nov-Dec. 17(6):15579883231204120. PMID: 37942721

HIV pre-exposure prophylaxis provision by U.S. Health centers in 2021.

Chinbunchorn T, Mayer KH, Campbell J, Alm DK, Krakower D, Marcus JL, Grasso C, Keuroghlian AS.

AIDS. 2023 Oct 31. PMID: 37905992

Advancing Pediatric Sexual Orientation and Gender Identity Data Collection.

Liu M, Grasso C, Kim HH, Mayer KH, Keuroghlian AS.

Am J Public Health. 2023 Oct 19. e1-e4. PMID: 37856729

Addressing mpox at a Frontline Community Health Center: Lessons for the Next Outbreak.

Allan-Blitz LT, Khan T, Elangovan K, Smith K, Multani A, Mayer KH.

Public Health Rep. 2023 Oct 17. 333549231201682. PMID: 37846528

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infections.

Mayer KH, Traeger M, Marcus JL.

JAMA. 2023 Oct 10. 330(14):1381-1382. PMID: 37738283

Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.

Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, Keefer M, Edupuganti S, Rodriguez B, Frank I, Scott H, Stranix-Chibanda L, Gurunathan S, Koutsoukos M, Van Der Meeren O, DiazGranados CA, Paez C, Andersen-Nissen E, Kublin J, Corey L, Ferrari G, Tomaras G, McElrath MJ.

J Infect Dis. 2023 Oct 05. PMID: 37795976

Assessing the associations between known genetic variants and substance use in people with HIV in the United States.

Haas CB, Jordahl KM, Nance RM, Whitney BM, Wang L, Delaney JAC, Ruderman S, Jia T, Mathews WC, Saag MS, Lee SA, Napravnik S, Jacobson JM, Chander G, McCall EM, Moore RD, Mayer KH, Mukherjee S, Lee WJ, Crane PK, Crane H, Peter I, Lindström S.

PLoS One. 2023. 18(10):e0292068. PMID: 37796845

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial.

Sobieszczyk ME, Mannheimer S, Paez CA, Yu C, Gamble T, Theodore DA, Chege W, Yacovone M, Hanscom B, Heptinstall J, Seaton KE, Zhang L, Miner MD, Eaton A, Weiner JA, Mayer K, Kalams S, Stephenson K, Julg B, Caskey M, Nussenzweig M, Gama L, Barouch DH, Ackerman ME, Tomaras GD, Huang Y, Montefiori D.

Lancet HIV. 2023 10. 10(10):e653-e662. PMID: 37802566